Journal Club

Arm Morbidity and Disability After Breast Cancer: New Directions for Care

Roanne L. Thomas-MacLean

Thomas F. Hack

Winkle Kwan

Anna Towers

Baukje Miedema

Andrea Tilley

surgery, postoperative, qualitative data analysis
ONF 2008, 35(1), 65-71. DOI: 10.1188/08.ONF.65-71

Purpose/Objectives: To chart the incidence and course of three types of arm morbidity (lymphedema, pain, and range of motion [ROM] restrictions) in women with breast cancer 6-12 months after surgery and the relationship between arm morbidity and disability.

Design: Longitudinal mixed methods approach.

Setting: Four sites across Canada.

Sample: 347 patients with breast cancer 6-12 months after surgery at first point of data collection.

Methods: Incidence rates were calculated for three types of arm morbidity, correlations between arm morbidity and disability were computed, and open-ended survey responses were compiled and reviewed.

Main Research Variables: Lymphedema, pain, ROM, and arm, shoulder, and hand disabilities.

Findings: Almost 12% of participants experienced lymphedema, 39% reported pain, and about 50% had ROM restrictions. Little overlap in the three types of arm morbidity was observed. Pain and ROM restrictions correlated significantly with disability, but most women did not discuss arm morbidity with healthcare professionals.

Conclusions: Pain and ROM restrictions are prevalent 6-12 months after surgery, but lymphedema is not. Pain and ROM restrictions are associated with disability.

Implications for Nursing: Screening for pain and ROM restrictions should be part of breast cancer follow-up care. Left untreated, arm morbidity could have a long-term effect on quality of life. Additional research into the longevity of various arm morbidity symptoms and possible interrelationships also is required.

Jump to a section

    References

    Armer, J., & Fu, M.R. (2005). Age differences in post-breast cancer lymphedema signs and symptoms. Cancer Nursing, 28(3), 200-207.
    Baker, F., Denniston, M., Zabora, J., Polland, A., & Dudley, W.N. (2002). A POMS short form for cancer patients: Psychometric and structural evaluation. Psycho-Oncology, 11(4), 273-281.
    Beaton, D.E., Davis, A.M., Hudak, P.L., & McConnell, S. (2001). The DASH (Disabilities of the Arm, Shoulder and Hand) outcome measure: What do we know about it now? British Journal of Hand Therapy, 6(4), 109-118.
    Bosompra, K., Ashikaga, T., O'Brien, P.J., Nelson, L., & Skelly, J. (2002). Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: A disablement process model perspective. Breast Journal, 8(6), 338-348.
    Carter, B.J. (1997). Women's experiences of lymphedema. Oncology Nursing Forum, 24(5), 875-882.
    Goffman, T.E., Laronga, C., Wilson, L., & Elkins, D. (2004). Lymphedema of the arm and breast in irradiated breast cancer patients: Risks in an era of dramatically changing axillary surgery. Breast Journal, 10(5), 405-411.
    Gummesson, C., Atroshi, I., & Ekdahl, C. (2003). The Disabilities of the Arm, Shoulder and Hand (DASH) outcome questionnaire: Longitudinal construct validity and measuring self-related health change after surgery. BMC Musculoskeletal Disorders, 4. Retrieved November 30, 2007, from http://www.ncbi.nlm.nih.gov http://www.ncbi.nlm.nih.gov
    Hack, T.F., Cohen, L., Katz, J., Robson, L.S., & Goss, P. (1999). Physical and psychological morbidity after axillary lymph node dissection for breast cancer. Journal of Clinical Oncology, 17(1), 143-149.
    Hayes, S., Battistutta, D., & Newman, B. (2005). Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Cancer Research and Treatment, 94(1), 1-10.
    Hayes, S., Cornish, B., & Newman, B. (2005). Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Research and Treatment, 89(3), 221-226.
    Hull, M.M. (2000). Lymphedema in women treated for breast cancer. Seminars in Oncology Nursing, 16(3), 226-237.
    International Society of Lymphology. (2003). The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology, 36(2), 84-91.
    Karges, J.R., Mark, B.E., Stikeleather, S.J., & Worrell, T.W. (2003). Concurrent validity of upper-extremity volume estimates: Comparison of calculated volume derived from girth measurements and water displacement volume. Physical Therapy, 83(2), 134-145.
    Kligman, L., Wong, R.K., Johnston, M., & Laetsch, N.S. (2004). The treatment of lymphedema related to breast cancer: A systematic review and evidence summary. Supportive Care in Cancer, 12(6), 421-431.
    Kwan, W., Jackson, J., Weir, L.M., Dingee, C., McGreggor, G., & Olivotto, I.A. (2002). Chronic arm morbidity after curative breast cancer treatment: Prevalence and impact on quality of life. Journal of Clinical Oncology, 20(20), 4242-4248.
    Lev, E.L., Paul, D., & Owen, S.V. (1999). Age, self-efficacy, and change in patients' adjustment to cancer. Cancer Practice, 7(4), 170-176.
    Magee, D.J. (1997). Orthopedic physical assessment (3rd ed.). Philadelphia: Saunders.
    Marcks, P. (1997). Lymphedema. Pathogenesis, prevention, and treatment. Cancer Practice, 5(1), 32-38.
    McNeely, M.L., Magee, D.J., Lees, A.W., Bagnall, K.M., Haykowsky, M., & Hanson, J. (2004). The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema: A randomized controlled trial. Breast Cancer Research and Treatment, 86(2), 95-106.
    Melzack, R. (1975). The McGill Pain Questionnaire: Major properties and scoring methods. Pain, 1(3), 277-299.
    Morrow, M., White, J., Moughan, J., Owen, J., Pajack, T., Sylvester, J., et al. (2001). Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. Journal of Clinical Oncology, 19(8), 2254-2262.
    National Cancer Institute. (2007). Lymphedema. Retrieved January 23, 2007, from http://www.cancer.gov/cancertopics/pdq/supportivecare/lymphedema/healthprofessional
    Rietman, J.S., Dijkstra, P.U., Geertzen, J.H., Baas, P., De Vries, J., Dolsma, W., et al. (2003). Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast carcinoma. Cancer, 98(4), 690-696.
    Sagen, A., Karesen, R., & Risberg, M.A. (2005). The reliability of a simplified water displacement instrument: A method for measuring arm volume. Archives of Physical Medicine and Rehabilitation, 86(1), 86-89.
    Soran, A., D'Angelo, G., Begovic, M., Ardic, F., Harlak, A., Samuel Wieand, H., et al. (2006). Breast cancer-related lymphedema—What are the significant predictors and how they affect the severity of lymphedema? Breast Journal, 12(6), 536-543.
    Stevens, P.E., Dibble, S.L., & Miaskowski, C. (1995). Prevalence, characteristics, and impact of postmastectomy pain syndrome: An investigation of women's experiences. Pain, 61(1), 61-68.
    Thomas-MacLean, R., Miedema, B., & Tatemichi, S.R. (2005). Breast cancer-related lymphedema: Women's experiences with an underestimated condition. Canadian Family Physician, 51, 246-247.
    van der Veen, P., De Voogdt, N., Lievens, P., Duguet, W., Lamote, J., & Sacre, R. (2004). Lymphedema development following breast cancer surgery with full axillary resection. Lymphology, 37(4), 206-208.
    Wilke, L.G., McCall, L.M., Posther, K.E., Whitworth, P.W., Reintgen, D.S., Leitch, A.M., et al. (2006). Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Annals of Surgical Oncology, 13(4), 491-500.